tebentafusp
Term · Oncology and biomedicine · MLC-T-ONC-008562
A drug used to treat adults with uveal melanoma (a type of eye cancer) that has spread or cannot be removed by surgery. It is used in patients who have the HLA-A*02:01 antigen. It is also being studied in the treatment of other types of cancer. Tebentafusp binds to certain antigens found on the surfaces of uveal melanoma cells and T cells (a type of immune cell). This may help the immune system kill cancer cells. Tebentafusp is a type of bispecific fusion protein. Also called Kimmtrak.
| Identifier | MLC-T-ONC-008562 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Kimmtrak |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008562",
"term": "tebentafusp",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with uveal melanoma (a type of eye cancer) that has spread or cannot be removed by surgery. It is used in patients who have the HLA-A*02:01 antigen. It is also being studied in the treatment of other types of cancer. Tebentafusp binds to certain antigens found on the surfaces of uveal melanoma cells and T cells (a type of immune cell). This may help the immune system kill cancer cells. Tebentafusp is a type of bispecific fusion protein. Also called Kimmtrak.",
"synonyms": [
"Kimmtrak"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/tebentafusp/"
}
Record 16,059 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.